Search Results 1131-1140 of 17835 for monoclonal antibody

1. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

2. Doctors and departments - Mayo Clinic

   Research. Researchers at Mayo Clinic coined the term monoclonal gammopathy of undetermined significance (MGUS) in the 1970s and continue to study this condition ...

3. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

   Prior immunotherapy & monoclonal antibody therapy are acceptable. Subjects who received prior cytotoxic chemotherapy after incomplete resection of ...

4. Publications - Regan N. Theiler, M.D., Ph.D. - Mayo Clinic

   Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in Pregnancy. ... Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild ...

5. A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody, daratumumab + bortezomib/thalidomide/dexamethasone \[D-VTd\] and daratumumab + bortezomib/ lenalidomide/dexamethasone \[D-VRd\]), or ...

6. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

   ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. * Has had a prior anti-cancer monoclonal antibody (mAb), excluding anti ...

7. Palivizumab (intramuscular route) - Side effects & uses - Mayo Clinic

   It belongs to a group of medicines known as immunizing agents. This medicine works by giving your body antibodies to protect it against RSV infection. RSV ...

8. A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma - Mayo Clinic

   Monoclonal antibodies within 28 days; Corticosteroid administration >20 mg/day of prednisone or equivalent within 14 days; Proteasome inhibitors within 14 ...

9. A Study To Evaluate The Safety And Effectiveness Of TEPEZZA® In Treating Patients With Chronic (Inactive) Thyroid Eye Disease - Mayo Clinic

   Treatment with any monoclonal antibody within 3 months prior to Screening. Identified pre-existing ophthalmic disease that, in the judgment of the ...

10. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...